What is GeneThera, Inc. (GTHR) stock price today?

GeneThera, Inc. (GTHR) is currently trading at $0.00.

What is GTHR P/E ratio?

GeneThera, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is GTHR return on equity (ROE)?

GeneThera, Inc.'s return on equity (ROE) is 12.50%, indicating how efficiently the company generates profit from shareholders' equity. This is above the market average.

What is GeneThera, Inc.'s market cap?

GeneThera, Inc. has a market capitalization of $3533.

OTC · Biotechnology

GeneThera, Inc. (GTHR) Stock

$0.00 OTC: GTHR Healthcare

GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases).

Valuation

Metric	Value
Price	$0.00
Market Cap	$3533
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$-0.04
52-Week High	$0.01
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	12.50%
ROA	—
ROCE	12.35%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	-0.12
Current Ratio	0.00

Annual Financials (USD)

Metric	2017	2018	2019	2020	2021
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-1.0M	$-4.0M	$-1.0M	$-1.0M	$-1.0M
Net Profit	$-1.0M	$-4.0M	$-1.0M	$-1.0M	$-1.0M
EPS	$-0.02	$-0.11	$-0.02	$-0.04	$-0.04
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2017	2018	2019	2020	2021
Total Assets	$0	$0	$0	$0	$0
Total Liabilities	$7.0M	$6.0M	$7.0M	$8.0M	$8.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$1.0M	$1.0M	$1.0M	$1.0M	$1.0M

Cash Flow (USD)

Metric	2017	2018	2019	2020	2021
Operating Cash Flow	$0	$0	$0	$0	$0
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$0	$0	$0	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.81
FCF Yield	-242.65%
Quick Ratio	0.00
Interest Coverage	-453.69
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AHPIQAllied Healthcare Products, Inc.	$0.00	—	—	$4010	0.00%
CRXMGene Biotherapeutics, Inc.	$0.00	—	0.00	$6493	0.00%
CRYOAmerican CryoStem Corporation	$0.00	—	0.00	$4428	0.00%
DMTKQDermTech, Inc.	$0.00	—	0.00	$3496	0.00%
EPRSQEPIRUS Biopharmaceuticals, Inc.	$0.00	—	—	$1571	0.00%

About GeneThera, Inc.

GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases). The company's portfolio includes treatments for a variety of these conditions, such as COVID-19, and illnesses like paratuberculosis (Johne's disease), currently in its Stage III clinical phase, as well as mad cow and chronic wasting diseases, and common bacterial infections like E.coli and salmonella. Furthermore, GeneThera is developing a vaccine specifically targeting Mycobacterium avium subspecies paratuberculosis bacteria. Utilizing its innovative Molecular Robotic/AI Platform and a strategic therapeutic framework, the company strives to inhibit the spread of animal-borne diseases and improve control over zoonotic infectious agents. GeneThera, Inc. operates out of Westminster, Colorado.

GeneThera, Inc. (GTHR) stock trades at $0.00 with a market capitalization of $3533. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, GeneThera, Inc. generates a return on equity (ROE) of 12.50%, above the typical market average, return on capital employed of 12.35%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.genethera.net

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides